Health and Wellness
The company will use the funds to advance the study of its neuromodulation device intended to treat Alzheimer's disease.
A study published in The New England Journal of Medicine found a closed-loop control system kept children's glucose levels in the target range longer than standard care.
It also received backing from the founding members of Grab and Zalora.
The acquisition includes Mindstrong's technology assets and some of its employees.
The program will be available through Amwell in the second half of 2023.
It now plans to release more hypnosis-based DTx apps for anxiety, sleep, and chronic pain.
The company will use the funds to circulate its ArteraAI Prostate Test and to develop tests to support individualized therapy options for other cancers.
Ida Tin, cofounder and chairwoman at Clue, explains how she sees the fall of Silicon Valley Bank affecting femtech investments and how the sector could progress fruitfully.
Fertility care is expensive and often hard to access. OCA Ventures' Dana Sun and Ellen Bursey explain the digital health landscape and offer advice for investors and founders in the space.
Also, Intellect has secured undisclosed investment from IHH Healthcare for its regional expansion.